|
Volumn 20, Issue 4, 2006, Pages
|
Fibroblast growth factor-2-retargeted adenoviral vector for selective transduction of primary glioblastoma multiforme endothelial cells.
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANTIVIRUS AGENT;
FIBROBLAST GROWTH FACTOR 2;
FIBROBLAST GROWTH FACTOR RECEPTOR;
GANCICLOVIR;
GREEN FLUORESCENT PROTEIN;
HYBRID PROTEIN;
THYMIDINE KINASE;
ADENOVIRUS;
APOPTOSIS;
ARTICLE;
BRAIN TUMOR;
CELL CULTURE;
DRUG EFFECT;
DRUG RESISTANCE;
ENDOTHELIUM CELL;
GENE THERAPY;
GENE VECTOR;
GENETIC TRANSDUCTION;
GENETICS;
GLIOBLASTOMA;
HUMAN;
METABOLISM;
METHODOLOGY;
NEOVASCULARIZATION (PATHOLOGY);
ONCOLYTIC VIROTHERAPY;
PATHOLOGY;
PATHOPHYSIOLOGY;
SUICIDE TRANSGENE;
VASCULARIZATION;
VIROLOGY;
ADENOVIRIDAE;
ANGIOGENESIS INHIBITORS;
ANTIVIRAL AGENTS;
APOPTOSIS;
BRAIN NEOPLASMS;
CELLS, CULTURED;
DRUG RESISTANCE;
ENDOTHELIAL CELLS;
FIBROBLAST GROWTH FACTOR 2;
GANCICLOVIR;
GENE THERAPY;
GENES, TRANSGENIC, SUICIDE;
GENETIC VECTORS;
GLIOBLASTOMA;
GREEN FLUORESCENT PROTEINS;
HUMANS;
NEOVASCULARIZATION, PATHOLOGIC;
ONCOLYTIC VIROTHERAPY;
RECEPTORS, FIBROBLAST GROWTH FACTOR;
RECOMBINANT FUSION PROTEINS;
THYMIDINE KINASE;
TRANSDUCTION, GENETIC;
|
EID: 33747159357
PISSN: None
EISSN: 10920684
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (8)
|
References (0)
|